chrisvoncsefalvay/vaers-outcomes huggingface dataset:
second pregnancy, baby is due September 24, 2022, fever, sever swelling, redness, entire left arm has pain, swelling pain and redness have increased significantly as days go by. seen Dr.  again on 8/04/2022, and was prescribed methylprednisolone dose pack and told to take Benadryl. She confirmed that the nurse who gave me the shot administered it into the wrong location.
Sore arm, tingling all over. Fatigue, palpitations, tachycardia, weight loss
Left arm swelled with pain and redness.  The area of the injection site became swollen and hard.  Urticaria developed up and down the entire  L arm. Patient was unable to lift her arm overhead due to pain and decreased range of motion.
Onset 3/14/08-per Mom had shots in office and "screaming and crying in pain; gave Tylenol. Crying and screaming to point won't eat. Decreased appetite now and can't calm him down."
09/21/2022 In the evening I had body aches in the evening and I felt miserable. I felt as if someone was beating on me and I was in a lot of pain. No fever, but a lot of pain. I went to bed and when I woke up I felt great with no symptoms. 09/26/2022 in the evening I felt very sick, I had chills and slept all day. I took a COVID-19 test and it was negative. The next day my left leg felt like I had a brick attached to my leg and it was on fire. My entire leg was completely swollen and told my husband to take me to the urgent care. I was afraid that it may be a blood clot. I was sent to get a scan of my leg and my leg was examined and she said there was no trauma to it however it was swollen and hot. Thankfully there was no blood clot from the scan and the Doctor told me that it was cellulitis. The doctor could not determine the cause and could not agree or disagree with it being caused by the vaccine. I took some medications to help with the symptoms however a few days after my symptoms went away I began to develop plantar fasciitis. Since then it was extremely hard to walk on my leg, placing pressure seemed to place more pain. I still am experiencing plantar fasciitis unfortunately and it is difficult to walk however my swelling has improved overall and I am still having skin color change in my leg due to the amount of swelling. It is more painful if I walk a lot or if I sit for a long time. Once I get to moving it I still feel pain however it is not enough to where I cannot walk.
Information has been received from a pharmacist concerning a patient who was vaccinated with ZOSTAVAX. The pharmacist reported that a physician's office stated a patient who was administered ZOSTAVAX developed chickenpox. As of 25-JUN-2007 the patient's chickenpox persisted. The physician had not been able to contact the patient to examine the rash or gather more information. Additional information has been requested.
DID NOT COMPLETE VIVOTIF ONE WEEK PRIOR TO TRAVEL; This spontaneous case report was received from a pharmacist (PVX2019-034) on 04-Jan-2019 and a follow-up was received on 07-Jan-2019. The report describes a male consumer who "did not complete Vivotif one week prior to travel". The consumer was receiving oral Vivotif (one dose every other day; lot no: 3003240) for typhoid fever prophylaxis.  It was reported that the consumer took the doses of Vivotif on 03-Jan-2019, 05-Jan-2019, 07-Jan-2019 and would take the last dose on 09-Jan-2019. He was travelling right away.  The action taken with Vivotif with respect to the event "did not complete Vivotif one week prior to travel" was not applicable.  The clinical outcome of the event "did not complete Vivotif one week prior to travel" was unknown.  Company's Comment: The causality of the event "did not complete Vivotif one week prior to travel" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "did not complete Vivotif one week prior to travel" was considered as not applicable.
This spontaneous report as received from a Registered Nurse refers to a 20 year old patient. On 30-MAY-1995, the patient was vaccinated with one dose of VARIVAX (merck) (lot # not reported). On 19-JUN-2008, the patient was vaccinated with another dose of VARIVAX (merck) (lot # not reported). The nurse reported that the patient's varicella titer showed negative when it was taken on 01-MAY-2013. At the time of reporting, the outcome of the event was unknown. Additional information has been requested.
24AUG94 parent reports pt had period of approx 2 hrs of bilat pupil dilation; no other sx, vision OK-LOC & mental state WNL; talked to PHD nurse who advised mom to check w/PMD; 25AUG95 contacted parent for f/u mom reports no further problem
Patient reported redness and swelling on arm 4 inches past injection site 2 days after the injection was given. Myself the pharmacist told patient she should discuss with doctor if he should examine for possible cellulitis. Did not hear from patient until today (6 days after injection). She said the redness and swelling had continued to spread to her torso and trunk of body up to her breast area. The redness and swelling subsided on its own before she reached an on call nurse. The nurse stated that she believes it was an allergic reaction to the vaccine.
9d post intramuscular injection with Moderna Covid-19 vaccine patient developed redness, swelling at inj site 8x9cm, recommendations of cool compress, zyrten and 1% hydrocortisone cream was initiated today.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients. On an unknown date, the patients were vaccinated with doses of GARDASIL (Lot # not reported) that were exposed to unsupported temperatures. No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
burn feeling on her arm; pain at the injection site; shoulder and arm have been hurting; shoulder and arm have been hurting; having a hard time getting dressed and lift her arm; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A 62-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date: unknown) via an unspecified route of administration on 30Apr2021 (at the age of 62-year-old) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccines included the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown) on 13Apr2021 as single dose for COVID-19 immunization. She stated that the nurse who administered the 2nd dose asked her to pull her arm down and had burn feeling on her arm when she received the shot on 30Apr2021. She had pain at the injection site. Her shoulder and arm have been hurting ever since she got the 2nd dose. She was having a hard time getting dressed and lift her arm in 2021. She wanted to know recommendations to manage the symptoms and how long usually the symptoms last. The outcome of events is unknown.  Information on the lot/batch number has been requested.
Pain at the injection site; Redness at injection site; Swelling at injection site; Striations running from the injection site to the back of arm and down arm; Bruising; Shoulder was painful; Shoulder had swelling; Feeling really lethargic; Feeling tired; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 73-year-old female patient who received Herpes zoster (Shingrix) (batch number 4H9G2, expiry date 25th September 2021) for prophylaxis.   On 17th July 2019, the patient received the 1st dose of Shingrix (intramuscular). On 17th July 2019, less than a day after receiving Shingrix, the patient experienced lethargy and tiredness. On 18th July 2019, the patient experienced injection site pain, injection site erythema, injection site swelling, stretch marks, contusion, shoulder pain and swollen joints. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site swelling, stretch marks, lethargy, tiredness, contusion, shoulder pain and swollen joints were recovered/resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling, stretch marks, lethargy, tiredness, contusion, shoulder pain and swollen joints to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix in the right arm. The pharmacist reported that the patient experienced pain, redness and swelling at the injection site. The patient also had striations running from the injection site to the back of her arm and down her arm. All the symptoms had resolved. The pharmacist reported that the patient experienced feeling really lethargic and tired. The day after vaccination, the patient noticed bruising, and her shoulder was also painful and had swelling.
Left shoulder swollen, reddened, warm 48 hours after administration .  Soreness and redness lasted for 3 weeks.  SVT post vaccine 72 hours for interval of 5 minutes.
On 8/12/99, the pt developed erythema multiforme, dx by a dermatologist. The erythema multiforme was treated with parenteral steroids.
he started experiencing some swelling and pain in the arm.; he started experiencing some swelling and pain in the arm.; This is a spontaneous report from a contactable consumer (patient's wife). A male patient of an unspecified age received bnt162b2 (BNT162B2, formulation: solution for injection, Batch/Lot number was not provided) via an unknown route of administration, administered on 11Feb2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 as DOSE 1, SINGLE for covid-19 immunisation. It was reported that after received the second dose of the Pfizer vaccine patient was told that it was okay to take pain relievers after vaccination. However, they also heard reports contradicting this saying that it might affect antibody production of the vaccine. Patient took some Aleve since he started experiencing some swelling and pain in the arm. Therapeutic measures were taken as a result of he started experiencing some swelling and pain in the arm. The outcome of events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
High fever 103, sever headache, bilateral lower back pain, hematuria, nausea, loss of taste and smell, fatigue,  Shortness of breath, cough, asthma exacerbation.
Some numbness to her right leg; Can't extend toes/feels as if her toes are contracted; Leg felt weak/ feels like she is moving her toes through wet cement; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Some numbness to her right leg), MOBILITY DECREASED (Can't extend toes/feels as if her toes are contracted), MUSCULAR WEAKNESS (Leg felt weak/ feels like she is moving her toes through wet cement) and PAIN IN EXTREMITY (Sore arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016C21A and 050C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Some numbness to her right leg), MOBILITY DECREASED (Can't extend toes/feels as if her toes are contracted), MUSCULAR WEAKNESS (Leg felt weak/ feels like she is moving her toes through wet cement) and PAIN IN EXTREMITY (Sore arm). At the time of the report, HYPOAESTHESIA (Some numbness to her right leg), MOBILITY DECREASED (Can't extend toes/feels as if her toes are contracted) and MUSCULAR WEAKNESS (Leg felt weak/ feels like she is moving her toes through wet cement) outcome was unknown and PAIN IN EXTREMITY (Sore arm) had resolved.            No concomitant medications were provided. Treatment included Acupressure and Herbal supplements.   This case was linked to MOD-2021-255869 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up received contains No new information.
Mother had called the After hrs service, on 4/21/16- reported redness/swelling/pain where immunization given. Size of a softball. Hot and hard to touch.
had very painful rt arm, unable to raise rt arm, rt arm tender to touch;was unable to sleep 10/13-10/14;c/o chest hurt-could not take a deep breath;seen by md on 10/15;started on cortisone, APAP w/codeine;
Narrative:  received Pfizer vaccine, had mild redness at injection site; 7 days later had throbbing arm pain, erythema at site, slowly resolving, not infected.
Pt presented back to clinic today with golf ball sized raised red area around injection site.  There was a small dime-sized purple bruise where needle entered skin and the bruise was surrounded by reddened area.  Pt states she had no other s/s.  She states the redness appeared "a few days ago".  It does not itch.
One and one half days post vax, this pt developed 105 degree temperature. Mother treated with Tylenol and Motrin to control temperature.
Patient woke up at midnight with chills and shivering. His right arm was sore and red where shot was administered, the redness was the size of a silver dollar.  At 5 or 6 am he did take his temperature and it was 100.5 degrees Fahrenheit.  He took Advil and stayed home from work. He stayed up until about 9 am and went back to bed.  He woke up again at 1130 am wet with sweat and had a fever of 101.3 degrees Fahrenheit. He took Tylenol, stayed up, ate a something, watched TV and started to feel a little better by 3 PM.  Next day no fever and did go to work.
over a month ago she had a shingles rash on left hip, this is the 4th time since getting SHINGRIX; The caller states she received dose 1 of SHINGRIX in 2019. She never had dose 2; This non-serious case was reported by a consumer via call center representative and described the occurrence of shingles in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingles prior to getting SHINGRIX vaccine in 2019 (the patient had shingles prior to getting SHINGRIX vaccine in 2019).   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles (Verbatim: over a month ago she had a shingles rash on left hip, this is the 4th time since getting SHINGRIX) and incomplete course of vaccination (Verbatim: The caller states she received dose 1 of SHINGRIX in 2019. She never had dose 2).  The outcome of the shingles was resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.     It was unknown if the company considered the shingles to be related to Shingrix.   Additional Information: GSK receipt date 6th Sep 2023 The patient received dose 1 of SHINGRIX in 2019. She never had dose 2. She stated a little over a month ago she had a shingles rash on left hip, this was the 4th time since getting SHINGRIX. She mentioned she had shingles (on left hip) prior to getting SHINGRIX in 2019. She would speak to her HCP ( would have an appointment on 7th September 2023) to decide if would get dose 2 of SHINGRIX soon.  Till the time of reporting the patient did not received 2nd dose which led to incomplete course of vaccination.  The reporter did not consent to follow-up.
Local soreness; Difficulty raising arm; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2020, the patient received Shingrix. On an unknown date, 3 weeks after receiving Shingrix, the patient experienced pain in arm and movement disorder. On an unknown date, the outcome of the pain in arm and movement disorder were unknown.   It was unknown if the reporter considered the pain in arm and movement disorder to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication.  After receiving dose of Shingrix, the patient experienced local soreness and difficulty raising arm. The reporter consent to follow up.
Sore arm; Pregnant patient received vaccine when she was 19 weeks and 3 days pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant patient received vaccine when she was 19 weeks and 3 days pregnant) and PAIN IN EXTREMITY (Sore arm) in a 36-year-old female patient (gravida 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 05-Nov-2020 and the estimated date of delivery was 16-Aug-2021. On 16-Nov-2020, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant patient received vaccine when she was 19 weeks and 3 days pregnant). On 25-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant patient received vaccine when she was 19 weeks and 3 days pregnant) had resolved and PAIN IN EXTREMITY (Sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Nov-2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided
Severe hyponatremia, seizure, vomiting. Required hospitalization, 3% hypertonic saline, consultation with neurology and nephrology. Initial sodium level 114 at discharge sodium was 136. She recovered and is well now.
Pins and needle sensation on her back and on her chest under her both arm pits; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Pins and needle sensation on her back and on her chest under her both arm pits) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050C21A and 050C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PARAESTHESIA (Pins and needle sensation on her back and on her chest under her both arm pits). At the time of the report, PARAESTHESIA (Pins and needle sensation on her back and on her chest under her both arm pits) outcome was unknown.            Concomitant products included Birth control medications.  No treatment information was provided.   Reporter did not allow further contact
Pt. received flu shot 11/12/2010. Came back to pharmacy to report a second time that she is still experiencing: soreness at site of injection, nerve pain extending down to elbow, knot at injection site which all limits her activities due to the pain.
Excessive hair fall; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Excessive hair fall) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (Excessive hair fall). At the time of the report, ALOPECIA (Excessive hair fall) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medicines were reported. No treatment information were reported.
The patient received an undiluent dose of the vaccine, this was administered less than 4 hours ago so nothing  to report AE yet.
COVID + on 10/18/2021. Pnuemonia due to COVID 19 virus. Altered menal status. Metabolic encephalopathy. New onset a-fib. ARDS. The patient was treated aggressively with IV steroids, remdesivir, and baricitinib.  The patient could not make it on his own.  He has to be intubated. He was able to be extubated. The patient was kept on Eliquis 5 mg p.o. twice daily.  His kidney function did resolve and came back to normal. Discharged to rehab.
COVID-19 symptoms started 04/23/22, tested positive at facility on 04/25/22 which came back positive on 04/26/22. It first started 04/23/22 with a runny nose and a sore throat but I brushed off the runny nose as allergies and the cough from singing at a concert the previous night. After 3 days it didn't go away and I was getting a headache and feeling exhausted. When I went to get tested and got a positive result, I quarantined immediately. I got the chills and cold sweats and had a lot of coughing. I didn't feel chest congestion set in until two nights later and would get shortness of breath just doing daily activities like taking a shower and walking to the kitchen and back. 3 days after the positive result my energy levels got back up. Now, it's dealing with the nasal congestion and runny nose. 04/27/22 I woke up in the middle of the night choking on phlegm and had nausea so my husband took me to the ER and they didn't do any medications but they did do a chest x-ray but those results haven't came back because their system was down. I was discharged from the ER within a few hours because I wasn't in respiratory distress.
Information has been received from a physician concerning a 12 year old female patient who was vaccinated IM with Gardasil (Lot # not reported). Concomitant therapy included Varivax, DTaP and Menactra. The patient was administered 4 vaccines and on her way out of the physician's office, she fainted. It was also noted that the patient experienced pain when Gardasil was administered. Additional information has been requested. This is one of several reports received from the same source. Initial and follow-up information has been received from a physician and a healthcare professional, concering a 17 year old (previously reported as 12 year old), female patient, with no significant medical history or known allergies, who was vaccinated IM with the second dose GARDASIL (lot # invalid). Concomitant therapy included VARIVAX, DTap and MENACTRA. There was no illness at the time of vaccination. The physician stated the patient was administered 4 vaccines and on her way out of the physician's office, she fainted. The healthcare professional added that the patient complained that the vaccination burned and hurt, and then 5 to 10 minutes later, she "passed out without complication." No further information is expected. This is one of several reports received from the same source.
Patient tested positive for COVID on April 9, 2023.  Pt admitted for Respiratory Failure and expired on May 7, 2023.
Patient was a 100-year-old Female, fully vaccinated with Pfizer on 01/12/2021. Admitted to hospital as she is tested positive for COVID-19 and passed away on 04/26/2021.